Cargando…
FcγRIIB regulates autoantibody responses by limiting marginal zone B cell activation
FcγRIIB is an inhibitory receptor expressed throughout B cell development. Diminished expression or function is associated with lupus in mice and humans, in particular through an effect on autoantibody production and plasma cell (PC) differentiation. Here, we analyzed the effect of B cell–intrinsic...
Autores principales: | Barlev, Ashley N., Malkiel, Susan, Kurata-Sato, Izumi, Dorjée, Annemarie L., Suurmond, Jolien, Diamond, Betty |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9435648/ https://www.ncbi.nlm.nih.gov/pubmed/35819855 http://dx.doi.org/10.1172/JCI157250 |
Ejemplares similares
-
Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus
por: Malkiel, Susan, et al.
Publicado: (2018) -
FcγRIIb Expression Is Decreased on Naive and Marginal Zone-Like B Cells From Females With Multiple Sclerosis
por: Trend, Stephanie, et al.
Publicado: (2021) -
Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
por: Stopforth, Richard J., et al.
Publicado: (2016) -
The Complex Association of FcγRIIb With Autoimmune Susceptibility
por: Verbeek, J. Sjef, et al.
Publicado: (2019) -
Dichotomy in FcγRIIB deficiency and autoimmune-prone SLAM haplotype clarifies the roles of the Fc receptor in development of autoantibodies and glomerulonephritis
por: Kanari, Yasuyoshi, et al.
Publicado: (2014)